Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] Dose Escalation Study for the Treatment of Advanced Solid Tumors: Phase 1 Clinical Trial

NCT06048367 is registered in ClinicalTrials.gov with Sichuan Enray Pharmaceutical Sciences Company as lead sponsor.

NCT NCT06048367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06048367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] Dose Escalation Study for the Treatment of Advanced Solid Tumors: Phase 1 Clinical Trial
Lead sponsor
Sichuan Enray Pharmaceutical Sciences Company
Phase
Phase 1
Overall status
Completed
Start date
November 17, 2022
Completion date
February 6, 2025
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor, breast cancer, cervical cancer, colorectal cancer, lung cancer, ovarian cancer, pancreas cancer, thyroid cancer, vulva cancer